University of Maryland, Baltimore (UMB) Grants GlycoMantra Exclusive License to Advance the Company’s Therapeutic Pipeline
The licensing agreement will accelerate the development of therapeutics to treat drug-resistant metastatic colorectal cancer 3/7/22 BALTIMORE, March 7, 2022 /PRNewswire/ — GlycoMantra, a University of Maryland, Baltimore (UMB) startup company developing therapeutics for unmet medical needs in prostate cancer, …